Revolutionizing treatment for patients in need
Scroll To Discover
About
We’re committed to delivering boundless therapeutic ingenuity
Tarsus Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company that embodies the values of commitment, empowerment, and teamwork. We aim to bring novel therapeutics to patients across a range of conditions with limited treatment options.
Pipeline
Novel therapies, beginning with the eye
For the millions of patients living with Demodex blepharitis, an FDA-approved treatment is on the horizon.
News & Media
Here is the latest from Tarsus
08/12/2021
Tarsus Pharmaceuticals, Inc. Appoints Pharmaceutical and Healthcare Industry Leader Rosemary A. Crane to Board of Directors
08/04/2021
Tarsus Pharmaceuticals, Inc. Reports Second Quarter 2021 Financial Results and Provides Business and Clinical Updates
07/24/2021
Tarsus Pharmaceuticals, Inc. Presents New Saturn-1 Pivotal Trial Data and Titan Real-World Prevalence Study Results at ASCRS 2021
15440 Laguna Canyon Road, Ste 160
Irvine, CA 92618
2021 Tarsus Pharmaceuticals, Inc. All rights reserved.
TARSUS and the associated logo are trademarks of Tarsus Pharmaceuticals, Inc.
Contact Tarsus
Please reach out to us using the form below.